John Colucci - Concepedia

Concepedia

Author

John Colucci

Merck Canada Inc. (Canada)

Also Known As

J. COLUCCI, J. Colucci, J. T. COLUCCI, JOHN COLUCCI, Jennifer Cristini Almeida Colucci, John Colucci, John T. Colucci

38

Publications

1.2K

Citations

18

H-Index

50

Concepts

All Affiliations

Merck Canada Inc. (Canada)Merck & Co., Inc., Rahway, NJ, USA (United States)TransCanada (Canada)University of Toronto New York University

JC

About

John Colucci is an author at Merck Canada Inc. (Canada) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	572
2	Natural Sciences	5	5	291
3	Engineering	4	4	223
4	Health Sciences	1	1	39
5	Public Health	1	1	46

John Colucci

×

21

Publications

1.2K

Citations

18

H-Index

	Year	Citations
Rapid simultaneous radioimmunoassay for triiodothyronine and thyroxine in unextracted serum Terunori Mitsuma, John Colucci, Charles S. Hollander Biochemical and Biophysical Research Communications AllergyThyroid DiseaseRadiopharmaceutical TherapyThyroid DisordersThyroid Hormone	1972	202
Selective, Reversible Caspase-3 Inhibitor Is Neuroprotective and Reveals Distinct Pathways of Cell Death after Neonatal Hypoxic-ischemic Brain Injury Byung Hee Han, Daigen Xu, Junjeong Choi, Journal of Biological Chemistry	2002	177
Total Synthesis of Ionomycin Using Ring-Opening Strategies Mark Lautens, John Colucci, Sheldon Hiebert, Organic Letters Polyether Antibiotic IonomycinMedicinal ChemistryBioorganic ChemistryEngineeringBiochemistry	2002	110
Total Synthesis of (+)-Ambruticin S Thomas A. Kirkland, John Colucci, Leo S. Geraci, Journal of the American Chemical Society Diversity Oriented SynthesisBioorganic ChemistryBiochemistryDonut IconNatural Sciences	2001	73
Total synthesis of (+)-ambruticin S Stephen M. Berberich, Robert J. Cherney, John Colucci, Tetrahedron Bioorganic ChemistryTotal SynthesisPharmacologySynthetic ChemistryNatural Product Synthesis	2003	59
Neuroprotective effects of M826, a reversible caspase‐3 inhibitor, in the rat malonate model of Huntington's disease Sylvie Toulmond, Keith Tang, Y Bureau, British Journal of Pharmacology	2004	56
Discovery of [(3-bromo-7-cyano-2-naphthyl)(difluoro)methyl]phosphonic acid, a potent and orally active small molecule PTP1B inhibitor Yongxin Han, Michel Belley, Christopher I. Bayly, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryDrug TargetBiochemistryNatural SciencesMedicine	2008	55
Differential Efficacy of Caspase Inhibitors on Apoptosis Markers during Sepsis in Rats and Implication for Fractional Inhibition Requirements for Therapeutics Nathalie Méthot, Jingqi Huang, Nathalie Coulombe, The Journal of Experimental Medicine MitophagyApoptosis MarkersImmunotoxicologyApoptosisImmunology	2004	53
Diastereoselective Intermolecular [4 + 3] Cycloadditions via an Extended Transition State: A Route to Enantiomerically Enriched Cycloadducts Mark Lautens, Renée Aspiotis, John Colucci Journal of the American Chemical Society Molecular SciencesEngineeringHeterocyclicEnantioselective SynthesisDonut Icon	1996	53
Discovery of MK-7246, a selective CRTH2 antagonist for the treatment of respiratory diseases Michel Gallant, Christian Beaulieu, Carl Berthelette, Bioorganic & Medicinal Chemistry Letters Respiratory DiseasesPharmacologyMechanism Of ActionSelective Crth2 AntagonistPharmacotherapy	2010	49

Page 1